Health
Jigawa Records Second Highest Takers of COVID-19 Vaccine
By Adedapo Adesanya
The World Health Organisation (WHO) has disclosed that Jigawa State recorded the second-highest takers of the Oxford-AstraZeneca COVID-19 vaccines in Nigeria after Lagos State.
In a press release, the world health body noted that Jigawa has the second-highest turnout for the vaccine.
According to WHO, authorities in the North-Western state of the federation received 68,520 doses of the vaccine and 33,508 persons have been vaccinated by March 29. The state has recorded 518 of the 162,593 COVID-19 cases in Nigeria by the same date.
“Only two weeks into the arrival of COVID-19 vaccines in Nigeria, Jigawa State is recording impressive results as authorities accelerate efforts to distribute doses of the AstraZeneca vaccine, millions of which are available across Nigeria.
“The vaccines were delivered to the country from the Serum Institute of India(SII) in early March,” the release noted.
According to Mr Hassan Shaibu Kwallam, the State Immunization Officer, the state had to face some challenges as there were claims of vaccines causing infertility in women while others have claimed that vaccines will be administered to the country’s political elite only.
But working with local communities, the state has overcome a huge part of the fear, state officials noted.
Getting Jigawa’s residents to turn out was possible largely due to the influence of traditional and religious leaders, according to Mr Kwallam.
“Our strategy has been a very simple one. We have the buy-in of the local health workers and we also have the cooperation of the traditional leaders. That has made the vaccination process go smoothly,” he added.
Nigeria received 3.9 million vaccines in March out of an expected 84 million doses through the COVAX Facility, co-led by Gavi, the Vaccine Alliance, WHO and the Coalition for Epidemic Preparedness Innovations(CEPI), in partnership with the United Nations Children’s Fund, the World Bank, and other partners. COVAX is one pillar of the Access to COVID-19 Tools (ACT) Accelerator, a global collaboration to hasten production and fair access to COVID-19 tests, treatments and vaccines.
An additional 41.3 million vaccine doses through the Africa vaccine acquisition task team(AVATT) and the African Union are expected in April.
Testimonies
On a recent weekday, community health worker, Mrs Balkisu Yahaya, bared her arm and felt the small prick of the needle as she got her first dose of the COVID-19 vaccine from a colleague. In return, Hajiya Balkisu vaccinated her colleague too. The two are health workers deployed as vaccination teams to immunise against the COVID-19 disease in Nigeria’s Jigawa State and are some of the first to get the jab.
“I have taken the first dose and I am now very very happy,” Hajiya Balkisu, who works at the Sakwaya Primary Healthcare Center in Dutse, the capital, said. “It’s good so I can protect myself first before protecting others.”
Mrs Balkisu says the turn out signifies some vaccination success despite instances of Covid-19 vaccine hesitancy among some residents.
Since the start of the pandemic last year, unfounded theories about the origin of COVID-19 as well as rumours about the vaccine’s safety have spread widely across the internet and social media space in Nigeria.
When it was time for His Royal Highness, the Emir of Hadejia to get his first jab on a recent Monday, he did it publicly, opting to take the vaccine at the Hadejia General Hospital in the Hadejia Local Government Area (LGA) where many in his community could see. After the Emir received the injection, he held up his green vaccine card, with a QR code stamped on it, for proof.
“I hope to dispel the rumours that a different vaccine, safer and more potent, is being administered to only very important personalities,” the Emir said. “Coming out like this will build trust and confidence in the minds of many that harbour this misconception and will lead to a higher turn-out for vaccine rollout. I am sure of it.”
Mr Ahmed Mohammed Sani, Emir of Gumel who received his vaccine last Wednesday says partnerships between local leaders and health workers increase chances of success when it comes to immunisation.
“I am presenting my humble self for the COVID-19 vaccination before all so everybody can do the same,” the Emir said.
“What we, as an emirate had successfully done during the polio eradication initiative, is a clear testimony of our sustained ability to convince our communities in support of any public health interventions brought up by the government.”
Only health workers like Mrs Balkisu and traditional leaders were targeted for the first phase of the roll-out, to protect health personnel and build trust among communities.
WHO noted that phase two (which targets adults aged 50 and older) and then phase three (for ages between 18 and 49) are due to have commenced. Those who successfully receive their first jabs are expected to take their second doses after 12 weeks.
No Need for Fear
Back in Jigawa, Mrs Balkisu said she has had to convince many that the slight fever some feel after taking the vaccine was normal – she felt it too and it went away in a day, she added.
Dr Sunday Audu, WHO Jigawa state coordinator echoed her message. “There is no reason for hesitancy. There have been no reports of any serious Adverse Effect Following Immunization (AEFI) in the state. It is only a minor inconvenience but it would be beneficial for more people to get their doses so we can protect ourselves and our neighbours.”
WHO has supported in training the 162 vaccination teams deployed across the 27 LGAs of Jigawa and added that it will continue supporting the coordination, training, monitoring and supervision of health care workers till all doses are used up.
“I will advise my colleagues and everyone else to put their mind at rest,” Mrs Balkisu added as she attended to people waiting to be vaccinated. “Don’t think too much about the inconvenience of the jab. Just relax and you will be fine. It’s much less painful than contracting Covid-19 and falling sick.”
Like Polio, Like COVID-19
It’s not the first time Jigawa has successfully immunized thousands despite some pockets of hesitancy, health authorities say. When the Polio disease was endemic in Nigeria and parents were reluctant to get their wards vaccinated, health workers also turned to traditional and religious leaders for advocacy support. This culminated in the huge success recorded in 2020 when Nigeria was declared polio-free after years of fighting the disease.
By Adedapo Adesanya
Nigeria has launched its first nationally representative survey on antimicrobial resistance to generate critical data to guide evidence-based policies, improve patient outcomes, and strengthen health system resilience.
Antimicrobial resistance occurs when bacteria, viruses, fungi, and parasites evolve to resist treatment, making infections harder to cure.
As a result, surveillance is essential to track resistance patterns, identify priority pathogens, and guide targeted interventions and with support from the World Health Organization (WHO) and other partners, the initiative marks a milestone in the country’s public health response.
Nigeria becomes the third country globally to partner with WHO on a national antimicrobial resistance survey. having been selected based on the country’s strong commitment to AMR surveillance, its updated WHO Nigeria NAP 2.0, and readiness to expand laboratory and data systems.
Africa’s most populous country ranks 20th globally for age-standardized mortality due to antimicrobial resistance . In 2019, an estimated 263,400 deaths in Nigeria were linked to it—more than the combined deaths from enteric infections, tuberculosis, respiratory infections, maternal and neonatal disorders, neglected tropical diseases, malaria, and cardiovascular diseases.
Globally, resistant infections in tertiary care settings cost between $2,371 and $29,289 per patient episode, extend hospital stays by an average of 7.4 days, and increase mortality risk by 84 per cent.
The survey will see the establishment of a national baseline on antimicrobial resistance prevalence to monitor interventions, assess the distribution, burden (morbidity, mortality, DALYs, cost), and diversity of AMR across regions and populations, as well as contribute to the global target of reducing AMR deaths by 10 per cent by 2030, in line with the political declaration endorsed at the 79th United Nations General Assembly in 2024.
It also seeks to strengthen routine antimicrobial resistance surveillance, including diagnostics, sample referral systems, and laboratory capacity.
Using WHO’s standardized methodology, the survey will run for 12–15 months and cover 40–45 randomly selected health facilities nationwide. Patients with suspected bloodstream infections (BSIs) will be identified using standard case definitions, and blood samples will be analysed in quality-assured laboratories.
Data will be collected across all age groups, covering clinical, demographic, laboratory, financial, and outcome indicators. Follow-up will occur at discharge, 28 days, and three months post-infection. The survey will sample approximately 35,000 patients suspected of BSIs to obtain around 800 isolates of the most common pathogens.
Dr Tochi Okwor, Acting Head, Disease Prevention and Health Promotion, Nigeria Centre for Disease Control and Prevention (NCDC) said, “With WHO’s support, we are confident the survey will generate the evidence needed to protect public health.”
WHO Representative in Nigeria, Dr Pavel Ursu, reaffirmed WHO’s commitment stating that ,“Nigeria is taking a decisive step toward combating AMR with an approach grounded in data, science, and measurable impact. This survey will provide the clarity needed to drive smarter policies, stronger surveillance, and better patient outcomes. Nigeria is laying the foundations for a resilient health system, one that protects lives, strengthens trust, and ensures that essential medicines remain effective for future generations.”
Adding her input, Dr Laetitia Gahimbare, Technical Officer at WHO Regional Office for Africa, added:“Strengthening surveillance enhances Nigeria’s capacity to detect and respond to AMR threats, supporting better patient outcomes, reinforcing health security, and building a resilient system.”
Professor Babatunde Ogunbosi, Paediatric Infectious Diseases Specialist at University College Hospital, Ibadan, highlighted the broader impact:, “This survey is about more than data. It’s about building national capacity for research, diagnostics, and policy. It integrates science into public health decision-making.”
By Modupe Gbadeyanka
One of the leading Health Maintenance Organisations (HMOs) in Nigeria, SUNU Health, has said its philosophy is proactive wellness, noting that this was why it recently partnered with The Divine Physician and St. Luke Catholic Chaplaincy Centre for a community health initiative.
The chief executive of the company, Dr Patrick Korie, said, “SUNU Health’s vision extends far beyond merely offering health packages and insurance.”
“We are fundamentally interested in proactive wellness—preventing illness rather than just treating it. This annual exercise is a crucial part of that commitment, and we will continue to champion it for as long as we exist,” he stressed.
The medical practitioner led the company’s annual Health Walk in Lagos on Saturday, November 8, 2025. The event drew hundreds of health enthusiasts, including the Chaplain of the centre, Rev Fr. John Okoria SJ.
His active participation reinforced the spiritual and moral commitment to holistic well-being, proving crucial in mobilizing staff and community members, thereby ensuring the vital wellness message reached a broad and deeply engaged audience.
The health walk covered several major streets in Lagos, starting from Ishaga Road and navigating through Itire Road, Randle Avenue, Akerele, Ogunlana Drive, and Workers Street before concluding back at the starting point. Following the vigorous walk, participants engaged in a session of high-energy aerobics and other outdoor exercises, reinforcing the day’s focus on fitness.
“We are delighted to champion this vital health initiative alongside the Catholic Chaplaincy Centre LUTH/CMUL. The turnout was truly delightful, reflecting the community’s deep desire to embrace wellness.
“Collaborations like this amplify our message and commitment to the Nigerian community,” the Brand and Corporate Communications Lead at SUNU Health, Mr Samuel Olayemi, stated.
By Adedapo Adesanya
Coronation Registrars Limited, a subsidiary of Coronation Group, in partnership with the Lagos State Blood Transfusion Committee (LSBTC), recently hosted a Blood Drive Initiative at the 5th floor of Coronation Group Plaza. The event saw over 80 staff donate blood to support critical healthcare needs in Lagos State.
The Blood Drive Initiative forms part of Coronation’s commitment to meaningful, human-centred corporate social responsibility, a direct, measurable, and life-saving effort that reflects the Group’s health and sustainability values.
As Prosperity Partners dedicated to creating sustainable wealth for clients and the African continent, Coronation recognises that true prosperity extends beyond financial returns to encompass the well-being of communities we serve.
The company noted that this initiative enabled it to deliver immediate social impact by supporting national blood supply shortfalls through employee-driven action, demonstrate leadership in health-focused CSR aligned with ESG goals and SDG 3 (Good Health & Well-being), strengthen internal culture by fostering employee engagement, empathy, and purpose in a safe, structured environment, and reinforce corporate reputation through public-facing acts of service, stakeholder trust, and media visibility.
Blood donation remains a critical need in Nigeria, where regular blood supply is essential for emergency care, surgeries, and treatment of various medical conditions. Each donation can save up to three lives, and the collective effort of Coronation employees will significantly impact patients in need across Lagos State healthcare facilities.
“This aligns seamlessly with Coronation’s broader sustainability agenda, which views healthcare access as fundamental to building prosperous communities across Africa,” the company said in a statement on Tuesday.
Partnering with a certified medical institution, the drive was professionally managed, medically compliant, and logistically efficient. Participants underwent necessary medical screening procedures to ensure donor fitness and safety. Following their donations, donors received refreshments and appreciation for their life-saving contribution.
“At Coronation, we believe in making a meaningful difference in the communities we serve,” said Mr Oluseyi Owoturo, Chief Executive Officer of Coronation Registrars Limited. “This Blood donation Initiative reflects our values in action, saving lives, building community, and positioning the company as a purpose-driven brand. We’re proud of our employees who stepped forward to donate blood and save lives. This is what sustainable impact looks like: tangible solutions that address real challenges facing our continent.”
The partnership with the Lagos State Blood Transfusion Committee ensured professional handling of the donation process, meeting all safety and quality standards for blood collection and storage.
Coronation Registrars Limited says it continues to demonstrate that corporate success goes hand-in-hand with social responsibility.
“This initiative reinforces the company’s purpose to create a prosperous future for clients and the African continent through transformational solutions,” it added.
-
Feature/OPED6 years agoDavos was Different this year
-
Travel/Tourism9 years ago
Lagos Seals Western Lodge Hotel In Ikorodu
-
Showbiz3 years agoEstranged Lover Releases Videos of Empress Njamah Bathing
-
Banking7 years agoSort Codes of GTBank Branches in Nigeria
-
Economy2 years agoSubsidy Removal: CNG at N130 Per Litre Cheaper Than Petrol—IPMAN
-
Banking3 years agoFirst Bank Announces Planned Downtime
-
Banking3 years agoSort Codes of UBA Branches in Nigeria
-
Sports3 years agoHighest Paid Nigerian Footballer – How Much Do Nigerian Footballers Earn